|
|
||||||||||
|
J Am Coll Cardiol, 1996; 27:517-527 © 1996 by the American College of Cardiology Foundation |
Department of Cardiology, The Research Institute, The Cleveland Clinic Foundation, Ohio 44195, USA.
Homocysteine is increasingly recognized as a risk factor for coronary artery disease. An understanding of its metabolism and of the importance of vitamins B6 and B12 and folate as well as enzyme levels in its regulation will aid the development of therapeutic strategies that, by lowering circulating concentrations, may also lower risk. Possible mechanisms by which elevated homocysteine levels lead to the development and progression of vascular disease include effects on platelets, clotting factors and endothelium. This review presents the clinical and basic scientific evidence supporting the risk and mechanisms of vascular disease associated with elevated homocysteine concentrations as well as the results of preliminary therapeutic trials.
This article has been cited by other articles:
![]() |
I. Craici, S. Wagner, and V. D. Garovic Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 249 - 259. [Abstract] [PDF] |
||||
![]() |
P. S. Myles, M. T. V. Chan, K. Leslie, P. Peyton, M. Paech, and A. Forbes Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery Br. J. Anaesth., June 1, 2008; 100(6): 780 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brasselet, R. Garnotel, A. Lafont, S. Perotin, F. Vitry, E. Durand, L. Ducher, J. Elaerts, D. Metz, and P. Gillery Prepercutaneous Coronary Intervention Plasma Homocysteine Concentration Is a Useful Predictor of Angioplasty-Induced Myocardial Damage Clin. Chem., December 1, 2005; 51(12): 2374 - 2377. [Full Text] [PDF] |
||||
![]() |
N. Tyagi, K. C. Sedoris, M. Steed, A. V. Ovechkin, K. S. Moshal, and S. C. Tyagi Mechanisms of homocysteine-induced oxidative stress Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2649 - H2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Lee, K.-M. Kim, S. Namkoong, C.-K. Kim, Y.-C. Kang, H. Lee, K.-S. Ha, J.-A Han, H.-T. Chung, Y.-G. Kwon, et al. Nitric Oxide Inhibition of Homocysteine-induced Human Endothelial Cell Apoptosis by Down-regulation of p53-dependent Noxa Expression through the Formation of S-Nitrosohomocysteine J. Biol. Chem., February 18, 2005; 280(7): 5781 - 5788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Smolkova, M. Dusinska, K. Raslova, M. Barancokova, A. Kazimirova, A. Horska, V. Spustova, and A. Collins Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk Mutagenesis, November 1, 2004; 19(6): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terzolo, B. Allasino, S. Bosio, E. Brusa, F. Daffara, M. Ventura, E. Aroasio, G. Sacchetto, G. Reimondo, A. Angeli, et al. Hyperhomocysteinemia in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3745 - 3751. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paradisi, F. Cucinelli, M. C. Mele, A. Barini, A. Lanzone, and A. Caruso Endothelial function in post-menopausal women: effect of folic acid supplementation Hum. Reprod., April 1, 2004; 19(4): 1031 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Powers, A. K. Majors, L. J. Kerchner, and K. P. Conrad Renal Handling of Homocysteine During Normal Pregnancy and Preeclampsia Reproductive Sciences, January 1, 2004; 11(1): 45 - 50. [Abstract] [PDF] |
||||
![]() |
S. Ernest, M. Carter, A. Hosack, D. Rosenblatt, E. Ross, and J. H. Nadeau Nutrigenes, Functional Genomics and Systems Biology J. Nutr., December 1, 2003; 133(12): 4267 - 4268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Powers, M. S. Dunbar, M. J. Gallaher, and J. M. Roberts The 677 C-T Methylenetetrahydrofolate Reductase Mutation Does Not Predict Increased Maternal Homocysteine During Pregnancy Obstet. Gynecol., April 1, 2003; 101(4): 762 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coffey, G. K. Crowder, and D. J. Cheek Reducing Coronary Artery Disease by Decreasing Homocysteine Levels Crit. Care Nurse, February 1, 2003; 23(1): 25 - 30. [Full Text] [PDF] |
||||
![]() |
H. Wang, X. Jiang, F. Yang, G. B. Chapman, W. Durante, N. E. S. Sibinga, and A. I. Schafer Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition Blood, February 1, 2002; 99(3): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Badner, D. Freeman, and J. D. Spence Preoperative Oral B Vitamins Prevent Nitrous Oxide-Induced Postoperative Plasma Homocysteine Increases Anesth. Analg., December 1, 2001; 93(6): 1507 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Garcia-Tevijano, C. Berasain, J. A. Rodriguez, F. J. Corrales, R. Arias, A. Martin-Duce, J. Caballeria, J. M. Mato, and M. A. Avila Hyperhomocysteinemia in Liver Cirrhosis: Mechanisms and Role in Vascular and Hepatic Fibrosis Hypertension, November 1, 2001; 38(5): 1217 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lavie, A. Perelman, and P. Lavie Plasma Homocysteine Levels in Obstructive Sleep Apnea : Association With Cardiovascular Morbidity Chest, September 1, 2001; 120(3): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knekt, A. Reunanen, G. Alfthan, M. Heliovaara, H. Rissanen, J. Marniemi, and A. Aromaa Hyperhomocystinemia: A Risk Factor or a Consequence of Coronary Heart Disease? Arch Intern Med, July 9, 2001; 161(13): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Poddar, N. Sivasubramanian, P. M. DiBello, K. Robinson, and D. W. Jacobsen Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells : Implications for Vascular Disease Circulation, June 5, 2001; 103(22): 2717 - 2723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A.-B. Badawy Moderate alcohol consumption as a cardiovascular risk factor: the role of homocysteine and the need to re-explain the 'French Paradox' Alcohol Alcohol., May 1, 2001; 36(3): 185 - 188. [Full Text] [PDF] |
||||
![]() |
S. E. Sanchez, C. Zhang, M. Rene Malinow, S. Ware-Jauregui, G. Larrabure, and M. A. Williams Plasma Folate, Vitamin B12, and Homocyst(e)ine Concentrations in Preeclamptic and Normotensive Peruvian Women Am. J. Epidemiol., March 1, 2001; 153(5): 474 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tribouilloy, M. Peltier, M. C. Iannetta Peltier, F. Trojette, M. Andrejak, and J.-P. M. Lesbre Plasma Homocysteine and Severity of Thoracic Aortic Atherosclerosis Chest, December 1, 2000; 118(6): 1685 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duan, T. Murohara, H. Ikeda, K.-i. Sasaki, S. Shintani, T. Akita, T. Shimada, and T. Imaizumi Hyperhomocysteinemia Impairs Angiogenesis in Response to Hindlimb Ischemia Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2579 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Badner, W. S. Beattie, D. Freeman, and J. D. Spence Nitrous Oxide-Induced Increased Homocysteine Concentrations Are Associated with Increased Postoperative Myocardial Ischemia in Patients Undergoing Carotid Endarterectomy Anesth. Analg., November 1, 2000; 91(5): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fleming and L. B. Boyd The Effect of High-Protein Diets on Coronary Blood Flow Angiology, October 1, 2000; 51(10): 817 - 826. [Abstract] [PDF] |
||||
![]() |
V. Shpichinetsky, I. Raz, Y. Friedlander, N. Goldschmidt, I. D. Wexler, A. Ben-Yehuda, and G. Friedman The Association between Two Common Mutations C677T and A1298C in Human Methylenetetrahydrofolate Reductase Gene and the Risk for Diabetic Nephropathy in Type II Diabetic Patients J. Nutr., October 1, 2000; 130(10): 2493 - 2497. [Abstract] [Full Text] |
||||
![]() |
L. M. Title, P. M. Cummings, K. Giddens, J. J. Genest Jr, and B. A. Nassar Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease J. Am. Coll. Cardiol., September 1, 2000; 36(3): 758 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Cooke, G. M. Eaton, G. Whitby, R. A. Kennedy, P. F. Binkley, M. L. Moeschberger, and C. V. Leier Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients J. Am. Coll. Cardiol., August 1, 2000; 36(2): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gottsater, I. Anwaar, K.-F. Eriksson, I. Mattiasson, F. Lindgarde, and A. Gottsater Homocysteine Is Related to Neopterin and Endothelin-1 in Plasma of Subjects with Disturbed Glucose Metabolism and Reference Subjects Angiology, June 1, 2000; 51(6): 489 - 497. [Abstract] [PDF] |
||||
![]() |
E. K. Hoogeveen, P. J. Kostense, C. Jakobs, J. M. Dekker, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes : 5-Year Follow-Up of the Hoorn Study Circulation, April 4, 2000; 101(13): 1506 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Woo, P. Chook, Y. I. Lolin, J. E. Sanderson, C. Metreweli, and D. S. Celermajer Folic acid improves arterial endothelial function in adults with hyperhomocystinemia J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2002 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawasaki, V. A Purvin, and R. A Burgett Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy Br. J. Ophthalmol., November 1, 1999; 83(11): 1287 - 1290. [Abstract] [Full Text] |
||||
![]() |
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1348 - 1359. [Full Text] [PDF] |
||||
![]() |
I. Bova, J. Chapman, C. Sylantiev, A. D. Korczyn, and N. M. Bornstein The A677V Methylenetetrahydrofolate Reductase Gene Polymorphism and Carotid Atherosclerosis Stroke, October 1, 1999; 30(10): 2180 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations : A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology Circulation, September 28, 1999; 100(13): 1481 - 1492. [Full Text] [PDF] |
||||
![]() |
W. I. Hussein, R. Green, D. W. Jacobsen, and C. Faiman Normalization of Hyperhomocysteinemia with L-thyroxine in Hypothyroidism Ann Intern Med, September 7, 1999; 131(5): 348 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen Ann Intern Med, September 7, 1999; 131(5): 376 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Friedman, N. Goldschmidt, Y. Friedlander, A. Ben-Yehuda, J. Selhub, S. Babaey, M. Mendel, M. Kidron, and H. Bar-On A Common Mutation A1298C in Human Methylenetetrahydrofolate Reductase Gene: Association with Plasma Total Homocysteine and Folate Concentrations J. Nutr., September 1, 1999; 129(9): 1656 - 1661. [Abstract] [Full Text] |
||||
![]() |
P. A. Outinen, S. K. Sood, S. I. Pfeifer, S. Pamidi, T. J. Podor, J. Li, J. I. Weitz, and R. C. Austin Homocysteine-Induced Endoplasmic Reticulum Stress and Growth Arrest Leads to Specific Changes in Gene Expression in Human Vascular Endothelial Cells Blood, August 1, 1999; 94(3): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ambrosi, P. H. Rolland, H. Bodard, A. Barlatier, P. Charpiot, G. Guisgand, A. Friggi, O. Ghiringhelli, G. Habib, G. Bouvenot, et al. Effects of folate supplementation in hyperhomocysteinemic pigs J. Am. Coll. Cardiol., July 1, 1999; 34(1): 274 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Lonn and S. Yusuf Evidence based cardiology: Emerging approaches in preventing cardiovascular disease BMJ, May 15, 1999; 318(7194): 1337 - 1341. [Full Text] |
||||
![]() |
B. Kristensen, J. Malm, T. K. Nilsson, J. Hultdin, B. Carlberg, G. Dahlen, and T. Olsson Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic Stroke Stroke, May 1, 1999; 30(5): 974 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Greenlund, S. R. Srinivasan, J.-H. Xu, E. Dalferes Jr, L. Myers, A. Pickoff, and G. S. Berenson Plasma Homocysteine Distribution and Its Association With Parental History of Coronary Artery Disease in Black and White Children : The Bogalusa Heart Study Circulation, April 27, 1999; 99(16): 2144 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Provan and D. F O'Shaughnessy Recent advances in haematology BMJ, April 10, 1999; 318(7189): 991 - 994. [Full Text] |
||||
![]() |
A. Gardemann, H. Weidemann, M. Philipp, N. Katz, H. Tillmanns, F. W. Hehrlein, and W. Haberbosch The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease Eur. Heart J., April 2, 1999; 20(8): 584 - 592. [Abstract] [PDF] |
||||
![]() |
R. W. Powers, L. A. Minish, D. L. Lykins, R. B. Ness, W. R. Crombleholme, and J. M. Roberts Methylenetetrahydrofolate Reductase Polymorphism, Folate, and Susceptibility to Preeclampsia Reproductive Sciences, March 1, 1999; 6(2): 74 - 79. [Abstract] [PDF] |
||||
![]() |
M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF] |
||||
![]() |
F. D. Loop Coronary artery surgery: the end of the beginning Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 554 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Austin, S. K. Sood, A. M. Dorward, G. Singh, S. G. Shaughnessy, S. Pamidi, P. A. Outinen, and J. I. Weitz Homocysteine-dependent Alterations in Mitochondrial Gene Expression, Function and Structure. HOMOCYSTEINE AND H2O2 ACT SYNERGISTICALLY TO ENHANCE MITOCHONDRIAL DAMAGE J. Biol. Chem., November 13, 1998; 273(46): 30808 - 30817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Jacobsen Acquired Hyperhomocysteinemia in Heart Transplant Recipients Clin. Chem., November 1, 1998; 44(11): 2238 - 2239. [Full Text] [PDF] |
||||
![]() |
H. Morita, H. Kurihara, S.-i. Tsubaki, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, K. Kitamura, and Y. Yazaki Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke in Japanese Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1465 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stein and P. E. McBride Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment Arch Intern Med, June 22, 1998; 158(12): 1301 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF] |
||||
![]() |
M. R. Malinow, P. B. Duell, D. L. Hess, P. H. Anderson, W. D. Kruger, B. E. Phillipson, R. A. Gluckman, P. C. Block, and B. M. Upson Reduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart Disease N. Engl. J. Med., April 9, 1998; 338(15): 1009 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Welch and J. Loscalzo Homocysteine and Atherothrombosis N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050. [Full Text] [PDF] |
||||
![]() |
J. G. Motwani and E. J. Topol Aortocoronary Saphenous Vein Graft Disease : Pathogenesis, Predisposition, and Prevention Circulation, March 10, 1998; 97(9): 916 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Robinson, K. Arheart, H. Refsum, L. Brattstrom, G. Boers, P. Ueland, P. Rubba, R. Palma-Reis, R. Meleady, L. Daly, et al. Low Circulating Folate and Vitamin B6 Concentrations : Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease Circulation, February 10, 1998; 97(5): 437 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustapha, A. Naso, M. Nahlawi, A. Gupta, K. L. Arheart, D. W. Jacobsen, K. Robinson, and V. W. Dennis Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease Circulation, January 20, 1998; 97(2): 138 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||